Not following the Canadian IP Blog yet?
Here are a few recent blog posts that may be of interest.
Teva Canada Innovations v. Canada (Attorney General)
Vermont Enacts a New Law to Reduce Frivolous Patent Suits
CIPO May Process Final Fees Faster than Expected
Chain of Title (Part 4 of an Occasional Series of Articles on Due Diligence)
Subscribe here to the Canadian IP Blog today
The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.
Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...
